Nicole D. Perry - 01 Jun 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Vice President - Accounting
Signature: /s/ David Watson, attorney-in-fact for Nicole Perry
Issuer symbol: APLS
Transactions as of: 01 Jun 2021
Net transactions value: -$52,640
Form type: 4
Filing time: 02 Jun 2021, 16:15:18 UTC
Next filing: 15 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Options Exercise	$3,760	+1,000	+21%	$3.76^*	5,847	01 Jun 2021	Direct	F1
transaction	APLS	Common Stock	Sale	$56,400	-1,000	-17%	$56.40	4,847	01 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-1,000	-11%	$0.000000	8,161	01 Jun 2021	Common Stock	1,000	$3.76	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This is a scheduled exercise from a 10B5-1 trading plan.
F2	This option was granted on July 31, 2015 and is fully vested.